Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Dividend Stock News: ConocoPhillips (COP) on Hydraulic Fracturing, Intel Corporation (INTC)’s Latest Chips, Bristol-Myers Squibb Co (BMY)’s Study Goal

Editor’s Note: ConocoPhillips (NYSE:COP), Intel Corporation (NASDAQ:INTC), Bristol-Myers Squibb Co (NYSE:BMY)

ConocoPhillips CEO Ryan Lance extolls virtues of hydraulic fracturing (Tulsa World)
As the CEO of ConocoPhillips (NYSE:COP), the largest independent oil company in the nation, Ryan Lance was happy to address the pros and cons of hydraulic fracturing – or “fracking” – but mostly the pros. At a forum in Bartlesville on Tuesday, Lance said he was with Sen. Charles Schumer, D-N.Y., recently when the contention came up that hydraulic fracturing is somehow demonic and shouldn’t be done. “What he doesn’t know is they have been fracking in New York in conventional vertical wells for 50 years,” Lance said.

Conocophillips (NYSE:COP)

IDF: Intel Debuts Latest vPro Chips for Business Devices (PC Magazine)
Intel Corporation (NASDAQ:INTC) on Wednesday introduced its first lineup of fourth-generation Core vPro processors at the Intel Developer Forum, highlighting some additions to the business-oriented vPro platform which bring it more in line with the needs of a mobile workforce. The new vPro parts are now shipping to computer makers and will start appearing in business laptops, ultrabooks, all-in-ones, desktops, tablets, and hybrid “2-in-1” devices which function as both tablets and laptops in “early 2014,” the company said.

Bristol-Myers skin cancer drug misses study goal (Yahoo! News)
Bristol-Myers Squibb Co (NYSE:BMY)’s skin cancer treatment Yervoy missed a main goal of achieving a significant improvement in overall survival compared to a fake drug when tested in patients with an advanced form of prostate cancer, the drugmaker said Thursday. The New York company said it studied Yervoy on patients with cancer that had spread beyond the prostate and had become resistant to standard hormonal treatment. These patients had already received radiation treatments and the chemotherapy drug docetaxel.

ConocoPhillips to partially shut Ekofisk platform (Upstream Online)
ConocoPhillips (NYSE:COP) will partially shut down a key platform at its Ekofisk field in the Norwegian North Sea next week for repairs. Ekofisk is one of the four crudes – along with Brent, Forties and Oseberg – that make up the Brent BFOE global oil benchmark. “We will be conducting repair work on the Ekofisk 2/4J processing platform,” The Houston-headquarted major told Reuters. “We take into account this type of activity in our overall business plans and expect the work will cause us to partly shut down the platform within the next week,” ConocoPhillips (NYSE:COP) said.

Intel to close Hudson plant, lay off 700 (Boston Globe)
The world’s leading chipmaker plans to stop making chips in Massachusetts. Intel Corporation (NASDAQ:INTC) said on Thursday that the company will close its factory in Hudson by the end of 2014, resulting in the loss of about 700 jobs. “The facility and the site do not meet the requirements that we need,” said Intel spokesman Chuck Mulloy. The factory, originally built by defunct computer company Digital Equipment Corp., was acquired by Intel in 1998. It uses chipmaking technology that’s more than a decade old, and four generations behind the equipment used in Intel Corporation (NASDAQ:INTC)’s most advanced factories.

Bristol-Myers Squibb GC Notches Corporate Practice Award (Law360)
The national organization representing in-house attorneys will recognize Bristol-Myers Squibb Co (NYSE:BMY)’s general counsel next month for promoting accountability and streamlining her department, the organization announced Tuesday. Sandra Leung, Bristol-Myers Squibb’s general counsel and corporate secretary, was named recipient of the Association of Corporate Counsel’s 2013 “Excellence in Corporate Practice Award,” to be presented at the group’s annual conference, to be held in Los Angeles in October. “From her role in redefining the relationship with outside counsel, to reducing costs and restructuring her law department to meet business objectives, she has helped Bristol-Myers Squibb Co (NYSE:BMY) thrive in an increasingly challenging business and regulatory environment,” ACC President and CEO Veta T. Richardson said in a statement.

Recommended Reading:

Continental Resources, Inc. (CLR), ConocoPhillips (COP), Devon Energy Corp (DVN): A Closer Look at How America’s Oil Champion Plans to Deliver

AstraZeneca plc (ADR) (AZN), Bristol Myers Squibb Co. (BMY), GlaxoSmithKline plc (ADR) (GSK): Diabetes Drugmakers and Their “Definitely Maybe” Moment

Texas Instruments Incorporated (TXN), Fairchild Semiconductor Intl Inc (FCS), Intel Corporation (INTC): The Chip That Changed the World

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!